NCT05933941

Brief Summary

Fibromyalgia (FM) is a disease characterized by widespread pain, fatigue and cognitive alterations, among other symptoms, neck pain being the most frequent and debilitating. Virtual reality (VR) has emerged as a breakthrough for the treatment of such chronic conditions. The objective of this study is to evaluate the efficacy of VR in the treatment of chronic neck pain in patients with FM. Material and methods: Single-blind randomized clinical trial study. Patients with FM who meet the inclusion criteria will be recruited and will be distributed into three groups (GC, G1, G2). G1 (VR + cervical mobility exercises), G2 (cervical mobility exercises), control group (CG). The treatment will be administered twice a week for 4 weeks. Measurements of variables such as FIQ, EQ-5D, kinesiophobia, pain (VAS and algometer), range of motion (ROM), fatigue and adherence to treatment will be performed. A follow-up is intended to be carried out 15 days and a month after the end of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 6, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

5 months

First QC Date

June 19, 2023

Last Update Submit

February 13, 2025

Conditions

Keywords

virtual realitychronic painexercisesfibromyalgia

Outcome Measures

Primary Outcomes (3)

  • Pain (VAS)

    visual analogic scale. the maximum value will be 10 and the minimum value will be 0. The higher the score, the more pain the patient will have.

    base line; after finishing the treatment (one month), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • Pain (algometry)

    Algometer. the maximum value will be 5 and the minimum value will be 0. The higher the score, the less pain the patient will have.

    base line; after finishing the treatment (one moth), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • Pain (NDI)

    Neck Disability Index. Score from 0 to 50. The higher the score, the greater the disability.

    base line; after finishing the treatment (one moth), 15 days after finishing the treatment and 30 days after finishing the treatment.

Secondary Outcomes (7)

  • Fatigue (BORG)

    base line; after finishing the treatment (one month), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • Range Of Movement (goniometry)

    base line; after finishing the treatment (one moth), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • Fibromyalgia Impact (FIQ)

    base line; after finishing the treatment (one month), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • Quality of life (EQ-5D)

    base line; after finishing the treatment (one month), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • Central Sensibilization (CSI)

    base line; after finishing the treatment (one month), 15 days after finishing the treatment and 30 days after finishing the treatment.

  • +2 more secondary outcomes

Study Arms (3)

Group 1

EXPERIMENTAL

This group will perform cervical mobility exercises and exercises with virtual reality glasses. 2 sessions will be held per week with a total of 8 sessions

Other: Virtual reality

Group 2

ACTIVE COMPARATOR

This group will only perform cervical mobility exercises at two sessions per week with a total of 8 sessions.

Other: Exercises

Control group

NO INTERVENTION

This group will not receive any treatment or perform any type of exercise during the duration of this study.

Interventions

This is a game set in space in which you pilot a spaceship and have to go through rings while dodging meteorites, all controlled by neck movements. Before starting the game, the assigned therapist is in charge of establishing the necessary movement parameters. In addition, the software allows you to modify the difficulty of the game. We will start the first 3 sessions in "easy" mode, where cervical mobility does not exceed 30º. The following 3 sessions will be configured in "medium" mode, reaching 60º of mobility. In the last 2 sessions, we will select the "hard" mode, which not only increases the speed of the spacecraft but also covers the entire range of cervical mobility.

Group 1

The patients perform mobility and strengthening exercises for the cervical region, in which they are required to complete 1 set of 10 repetitions for each exercise. The patient should rest for at least 30 seconds between exercises.

Group 2

Eligibility Criteria

Age20 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fibromyalgia condition
  • present neck pain during the last 3 months

You may not qualify if:

  • present any pathology that contraindicates the use of virtual reality
  • being pregnant at the moment of the study.
  • not accepting the informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Camilo José Cela

Madrid, 28692, Spain

Location

MeSH Terms

Conditions

FibromyalgiaChronic PainMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Edurne Ú Úbeda Docasar, Doctor

    Associate Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor Edurne Úbeda D'Ocasar

Study Record Dates

First Submitted

June 19, 2023

First Posted

July 6, 2023

Study Start

April 1, 2024

Primary Completion

September 4, 2024

Study Completion

February 1, 2025

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations